Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
复制标题
DOI:
10.1016/j.jhep.2021.04.049
复制
发表时间:
2021-09-15
影响因子:
25.7
通讯作者:
Llovet, Josep M.
中科院分区:
文献类型:
--
作者:
Pinyol, Roser;Torrecilla, Sara;Llovet, Josep M.
Background and Aims: Non-alcoholic steatohepatitis (NASH)-related hepatocellular carcinoma (HCC) is increasing globally, but its molecular features are not well defined. We aimed to identify unique molecular traits characterising NASH-HCC compared to other HCC aetiologies.Methods: We collected 80 NASH-HCC and 125 NASH samples from 5 institutions. Expression array (n = 53 NASH-HCC; n = 74 NASH) and whole exome sequencing (n = 52 NASH-HCC) data were compared to HCCs of other aetiologies (n = 184). Three NASH-HCC mouse models were analysed by RNA-seq/expression-array (n = 20). Activin A receptor type 2A (ACVR2A) was silenced in HCC cells and proliferation assessed by colorimetric and colony formation assays.Results: Mutational profiling of NASH-HCC tumours revealed TERT promoter (56%), CTNNB1 (28%), TP53 (18%) and ACVR2A (10%) as the most frequently mutated genes. ACVR2A mutation rates were higher in NASH-HCC than in other HCC aetiologies (10% vs. 3%, p